Table 2.
Pre-ADT Era | Post-ADT Era | p-Value † | |||
---|---|---|---|---|---|
2016.11–2017.10 | 2017.11–2018.10 | 2018.11–2019.10 | 2019.11–2020.6 | ||
Evaluation, n (% of ADT consulted case) | |||||
Laryngoscopy | 774 | 813 | 998 (2.2) | 417 (10.3) | <0.0001 |
Chest CT | 642 | 711 | 632 (5.7) | 447 (8.3) | 0.1525 |
Bronchoscopy | 43 | 55 | 53 (9.4) | 82 (41.5) | <0.0001 |
Esophagography | 165 | 175 | 257 (11.3) | 153 (27.5) | <0.0001 |
VFSS | 115 | 121 | 200 (23.0) | 127 (37.0) | <0.0001 |
MII-pH | 62 | 82 | 109 (26.6) | 89 (42.7) | <0.0001 |
Intervention, n (% of ADT consulted case) | |||||
Tracheostomy | 34 | 27 | 16 (0.0) | 21 (19.1) | 0.3207 |
Gastrostomy | 51 | 44 | 49 (8.2) | 30 (46.7) | 0.3723 |
Fundoplication | 38 | 36 | 39 (12.8) | 39 (46.2) | 0.0311 |
LMS | 9 | 8 | 15 (13.3) | 23 (34.8) | <0.0001 |
Bougination | 1 | 1 | 0 (0.0) | 11 (27.3) | 0.0022 |
ADT, Aerodigestive team; CT, computed tomography; LMS, Laryngomicrosurgery; MII-pH, multichannel intraluminal impedance-pH monitoring; VFSS, videofluoroscopic swallow study. † Chi-square test was used for the statistical analysis. Ratio of evaluations and interventions to hospitalized patients number were compared between before and after ADT.